SCHEMBL30701909

SCHEMBL30701909

CC(C)(C)OC(=O)N1CCC(n2ccc(-c3cncc(O)c3)n2)CC1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 15/20 0.43
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41
HTT P42858 1/20 0.41
MET P08581 1/20 0.40
ABL1 P00519 1/20 0.40
EGFR P00533 1/20 0.40
SRC P12931 1/20 0.40
ABL2 P42684 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30701921 1.00 GPR119 (0.43) GPR119PTPN2PTPN1PTPN6HTT
SCHEMBL1781995 0.83 USP30 (0.53) GPR119PTPN2PTPN1PTPN6EGFR
SCHEMBL30701907 0.81 CCNC (0.51) GPR119METDDB1CRBN
SCHEMBL29945868 0.79 GPR119 (0.48) GPR119PTPN2PTPN1PTPN6HTT
SCHEMBL31466305 0.78 HTT (0.44) GPR119PTPN2PTPN1PTPN6HTT
SCHEMBL24278460 0.77 HTT (0.45) GPR119PTPN2PTPN1PTPN6HTT
SCHEMBL15950964 0.77 GPR119 (0.50) GPR119PTPN2PTPN1PTPN6HTT
SCHEMBL1557907 0.76 CTSD (0.49) GPR119PTPN2PTPN1PTPN6HTT
SCHEMBL1582522 0.76 GPR119 (0.47) GPR119PTPN2PTPN1PTPN6HTT
SCHEMBL27459322 0.76 GPR119 (0.47) GPR119PTPN2PTPN1PTPN6HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4554936-A1 CRIZOTINIB ANALOGUES AS SHIP1 INHIBITORS USEFUL TO TREAT ALZHEINER'S DISEASES The Trustees of Indiana University (US) 2025-05-21 EP disclosed
WO-2024015759-A1 CRIZOTINIB ANALOGUES AS SHIP1 INHIBITORS USEFUL TO TREAT ALZHEINER'S DISEASES THE TRUSTEES OF INDIANA UNIVERSITY (US) 2024-01-18 WO disclosed